-
The most shocking of the recent laboratory mishaps and biosafety breaches was the discovery of a long-forgotten cache of live smallpox in a lab storage area at the National Institutes of Health in Bethesda, MD.
-
Federal public health officials recently contacted clinicians at the Nebraska Biocontainment Patient Care Unit in Omaha to determine if the facility could house Ebola patients if needed as the record outbreak in Western Africa continues.
-
Dosing of beta-lactam antibiotics in critically ill patients is often inadequate and results in poor clinical outcomes.
-
There was no evidence of significant benefit from the administration of the antiviral agent, celgosivir, in the treatment of patients with dengue fever.
-
A 58-year-old woman from Southern Australia with a history of medically-managed liver abscess eight months prior to admission and recurrent urinary tract infections presented to our hospital with two weeks of fever and right upper quadrant.
-
As the first cases of Ebola ever treated in the U.S. were recently admitted to a special containment unit at Emory University Hospital in Atlanta, clinicians and public health officials continued to reassure a jittery public that infection control measures would prevent transmission and contain the virus.
-
A series of biosafety breaches in federal labs working with highly pathogenic agents has created a rift in the research community, with some calling for a moratorium until safety can be assured and other scientists arguing that this important work should continue with appropriate precautions to prepare for pandemics and bioterror attacks.
-
-
A prospective case series that included patients with recurrent Clostridium difficile infection found that treatment with tapered antibiotic therapy and the probiotic drink kefir resulted in a clinical cure of 84% (21 out of 25 patients).
-
Approximately half of blood cultures taken from febrile infants with bacteremia turn positive within 15 hours of sampling.